ALIVUS LIFE SCIENCES
Back to Income Statement
|
ALIVUS LIFE SCIENCES Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,283 Cr | ₹2,161 Cr | ₹2,123 Cr | ₹1,885 Cr | ₹1,537 Cr |
What is the latest Revenue of ALIVUS LIFE SCIENCES ?
Year | Revenue |
---|---|
Mar2024 | ₹2,283 Cr |
Mar2023 | ₹2,161 Cr |
Mar2022 | ₹2,123 Cr |
Mar2021 | ₹1,885 Cr |
Mar2020 | ₹1,537 Cr |
How is Revenue of ALIVUS LIFE SCIENCES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,283 Cr | 5.64 | |
Mar2023 | ₹2,161 Cr | 1.79 | |
Mar2022 | ₹2,123 Cr | 12.63 | |
Mar2021 | ₹1,885 Cr | 22.63 | |
Mar2020 | ₹1,537 Cr | - |
Compare Revenue of peers of ALIVUS LIFE SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ALIVUS LIFE SCIENCES | ₹12,115.4 Cr | -6% | -3.4% | 9.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
ALIVUS LIFE SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ALIVUS LIFE SCIENCES | -6% |
-3.4% |
9.9% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses